Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

PLC Systems' CO2 Heart Laser deemed effective in angina patients

June 28, 1996

Phospholipase A2 inhibitors for atherosclerosis treatment

June 28, 1996

Sankyo will seek FDA approval for temocapril HCl in 1997

June 28, 1996

Neurex seeks FDA approval for Corlopam

June 28, 1996

Endothelin antagonists in Kyowa Hakko's pipeline

June 28, 1996

Angiotensin II antagonists described by Sankyo

June 28, 1996

Roberts' ProAmatine approaches FDA approval

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

L-arginine is effective in heart failure patients

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...